In Vitro Efficacy of Moxidectin versus Ivermectin against Sarcoptes scabiei
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Moxidectin is under consideration for development as a treatment for human scabies. As some arthropods show decreased sensitivity to moxidectin relative to ivermectin, it was important to assess this for Sarcoptes scabiei . In vitro assays showed that the concentration of moxidectin required to kill 50% of mites was lower than that of ivermectin (0.5 μM versus 1.8 μM at 24 h; P < 0.0001). This finding provides further support for moxidectin as a candidate for the treatment of human scabies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moxidectin and the avermectins: Consanguinity but not identity
Prichard, R., Ménez, C., & Lespine, A. (2012) · International Journal for Parasitology: Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2012.04.001 · Cited by 439 · cited 1×
“ABC transporter-mediated efflux, for example (21).”
Mass drug administration for scabies control in a population with endemic disease.
Romani, L., Whitfeld, M. J., Koroivueta, J., Kama, M., Wand, H., Tikoduadua, L., Tuicakau, M., Koroi, A., Andrews, R., Kaldor, J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500987 · Cited by 268
Cited by
A Review of Scabies: An Infestation More than Skin Deep
Chandler, D. J., & Fuller, L. C. (2019) · Dermatology · doi:10.1159/000495290 · Cited by 259
Integrated Management of Skin NTDs—Lessons Learned from Existing Practice and Field Research
Yotsu, R. R. (2018) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed3040120 · Cited by 65
“The development of moxidectin, a macrocyclic lactone similar to ivermectin, but with a much longer half-life, for the treatment of human scabies may promote MDAs for scabies [43,44].”
BackgroundScabies: a neglected global disease.
Leung, A. K. C., Lam, J. M., & Leong, K. F. (2020) · Current Pediatric Reviews · doi:10.2174/1573396315666190717114131 · Cited by 82
Metadata
- Authors
- Mounsey, K. E., Walton, S. F., Innes, A., Cash-Deans, S., & McCarthy, J. S.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2017-08
- Volume
- 61
- Issue
- 8
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2617547881
- Cited by
- 41
- References
- 2
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vitro Efficacy of Moxidectin versus Ivermectin against Sarcoptes scabiei. https://app.cochat.ai/papers/10.1128/aac.00381-17
- The paper
- Mounsey, K. E., Walton, S. F., Innes, A., Cash-Deans, S., & McCarthy, J. S. (2017). In Vitro Efficacy of Moxidectin versus Ivermectin against Sarcoptes scabiei. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00381-17
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.